404 related articles for article (PubMed ID: 8099482)
1. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Rempel NL; Callaway CW; Geyer MA
Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic 5-HT(1A) and 5-HT(1B) receptor modulation of RU 24969-induced behavioral profile in rats.
Martinez-Price DL; Geyer MA
Pharmacol Biochem Behav; 2002 Apr; 71(4):569-80. PubMed ID: 11888548
[TBL] [Abstract][Full Text] [Related]
3. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
Callaway CW; Geyer MA
J Pharmacol Exp Ther; 1992 Oct; 263(1):318-26. PubMed ID: 1357158
[TBL] [Abstract][Full Text] [Related]
4. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Callaway CW; Wing LL; Geyer MA
J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA
Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
McCreary AC; Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
[TBL] [Abstract][Full Text] [Related]
7. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
Callaway CW; Rempel N; Peng RY; Geyer MA
Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
[TBL] [Abstract][Full Text] [Related]
8. Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.
Aronsen D; Bukholt N; Schenk S
Psychopharmacology (Berl); 2016 Apr; 233(8):1339-47. PubMed ID: 26856853
[TBL] [Abstract][Full Text] [Related]
9. Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats.
Krebs KM; Geyer MA
Psychopharmacology (Berl); 1993; 113(2):284-7. PubMed ID: 7855195
[TBL] [Abstract][Full Text] [Related]
10. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.
Fletcher PJ; Sinyard J; Higgins GA
Psychopharmacology (Berl); 2006 Sep; 187(4):515-25. PubMed ID: 16832658
[TBL] [Abstract][Full Text] [Related]
11. MDMA self-administration fails to alter the behavioral response to 5-HT(1A) and 5-HT(1B) agonists.
Aronsen D; Schenk S
Psychopharmacology (Berl); 2016 Apr; 233(7):1323-30. PubMed ID: 26856854
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic functions in arousal and motor activity.
Geyer MA
Behav Brain Res; 1996; 73(1-2):31-5. PubMed ID: 8788473
[TBL] [Abstract][Full Text] [Related]
13. GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat.
Chaouloff F; Courvoisier H; Moisan MP; Mormède P
Psychopharmacology (Berl); 1999 Jan; 141(3):326-31. PubMed ID: 10027515
[TBL] [Abstract][Full Text] [Related]
14. Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats.
Halberstadt AL; Buell MR; Price DL; Geyer MA
Pharmacol Biochem Behav; 2012 Jul; 102(1):88-94. PubMed ID: 22487771
[TBL] [Abstract][Full Text] [Related]
15. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
Fletcher PJ; Korth KM; Robinson SR; Baker GB
Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 5-HT
McDougall SA; Robinson JAM; Ramirez EL; Diaz HA
Pharmacol Biochem Behav; 2020 Feb; 189():172857. PubMed ID: 31958472
[TBL] [Abstract][Full Text] [Related]
17. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Fantegrossi WE; Kiessel CL; De la Garza R; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
[TBL] [Abstract][Full Text] [Related]
18. RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors.
Fletcher PJ; Korth KM
Behav Pharmacol; 1999 Mar; 10(2):183-93. PubMed ID: 10780831
[TBL] [Abstract][Full Text] [Related]
19. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
Spanos LJ; Yamamoto BK
Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
[TBL] [Abstract][Full Text] [Related]
20. Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor.
Scearce-Levie K; Viswanathan SS; Hen R
Psychopharmacology (Berl); 1999 Jan; 141(2):154-61. PubMed ID: 9952039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
